Celltrion
068270 · KRX / KOSPI · Biopharmaceuticals
Tentang perusahaan
Celltrion is South Korea's leading biopharmaceutical company, specializing in the development and manufacturing of biosimilar antibody drugs for conditions such as rheumatoid arthritis (Remsima/Inflectra) and cancer. It was one of the first companies globally to successfully commercialize a monoclonal antibody biosimilar. Celltrion operates a large biotechnology campus in Incheon.
| Bursa | KRX / KOSPI |
| Kode saham | 068270 |
| Sektor | Biopharmaceuticals |
| Kapitalisasi pasar indikatif USD | $14.00B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (KRX / KOSPI), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Korea Exchange — pencatatan resmi di bursa
Hanya informasi ketersediaan, bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di South Korea
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset, bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.